Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
intrathecally) dose-dependently prevents CFA-induced pain behavior and the associates SGK1 phosphorylation
and potential for combination in preclinical models
At 5 μM it directly inhibits DUB activity of USP9x
which induces NAD depletion
MGCD0103 - CAS# 726169-73-9 Catalog No.:M6555-10 intrathecally) dose-dependently prevents CFA-induced painMGCD0103, also known as Mocetinostat, CAS No. 726169 73 9, is a rationally designed, orally available, Class 1 selective, small molecule, 2 aminobenzamide HDAC inhibitor with potential antineoplastic activity. MGCD0103 binds to and inhibits Class 1 isoforms of HDAC, specifically HDAC 1, 2 and 3, which may result in epigenetic changes in tumor cells and so tumor cell death; although the exact mechanism has yet to be defined, tumor cell death may occur
US$ 32.92
US$ 10.14
US$ 43.73